ID

4921

Beschreibung

ODM derived from http://clinicaltrials.gov/show/NCT00531206

Link

http://clinicaltrials.gov/show/NCT00531206

Stichworte

Versionen (2)
  1. 14.04.14 14.04.14 - Julian Varghese
  2. 22.05.15 22.05.15 - Martin Dugas
Hochgeladen am

14. April 2014

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0 Legacy
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility NCT00531206 HIV Infections

Deutsch Englisch

Eligibility

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility
Einschlusskriterien
Beschreibung

Einschlusskriterien

Alias
UMLS CUI 2011AA
CL425202
Alter mindestens 18 Jahre
Beschreibung

age at least 18 Years

Datentyp

boolean

Alias
UMLS CUI 2011AA
C0001779
SNOMED CT 2011_0131
397669002
Highly pre-treated male and female adult patients with virus resistant to multiple protease inhibitors. Aptivus (tipranavir), co-administered with low dose Norvir (ritonavir), is indicated for combination antiretroviral treatment of HIV-1 infection in highly pre-treated adult patients with virus resistant to multiple protease inhibitors.
Beschreibung

Highly pre-treated male and female adult patients with virus resistant to multiple protease inhibitors. Aptivus (tipranavir), co-administered with low dose Norvir (ritonavir), is indicated for combination antiretroviral treatment of HIV-1 infection in highly pre-treated adult patients with virus resistant to multiple protease inhibitors.

Datentyp

boolean

Alias
UMLS CUI 2011AA
C0205250
SNOMED CT 2011_0131
75540009
UMLS CUI 2011AA
C1514463
UMLS CUI 2011AA
C0024554
SNOMED CT 2011_0131
248153007
HL7 V3 2006_05
M
UMLS CUI 2011AA
C0015780
SNOMED CT 2011_0131
248152002
HL7 V3 2006_05
F
UMLS CUI 2011AA
C0700597
SNOMED CT 2011_0131
41847000
UMLS CUI 2011AA
C1444092
SNOMED CT 2011_0131
409795000
UMLS CUI 2011AA
C0439064
SNOMED CT 2011_0131
255204007
UMLS CUI 2011AA
C0033607
SNOMED CT 2011_0131
412127001
UMLS CUI 2011AA
C1612190
UMLS CUI 2011AA
CL415222
UMLS CUI 2011AA
C1521801
UMLS CUI 2011AA
C1708745
UMLS CUI 2011AA
C0292818
SNOMED CT 2011_0131
386896009
LOINC Version 232
MTHU013855
UMLS CUI 2011AA
C1444656
SNOMED CT 2011_0131
410535002
UMLS CUI 2011AA
C0556895
SNOMED CT 2011_0131
229554006
UMLS CUI 2011AA
C1963724
MedDRA 14.1
10067326
LOINC Version 232
MTHU000163
UMLS CUI 2011AA
C2363741
MedDRA 14.1
10068341
UMLS CUI 2011AA
C0011900
SNOMED CT 2011_0131
439401001
LOINC Version 232
MTHU008876
Ausschlusskriterien
Beschreibung

Ausschlusskriterien

Alias
UMLS CUI 2011AA
CL425201
Alter < 18 Jahre
Beschreibung

Age < 18 years

Datentyp

boolean

Alias
UMLS CUI 2011AA
C0001779
SNOMED CT 2011_0131
397669002
pregnant female patients
Beschreibung

pregnant female patients

Datentyp

boolean

Alias
UMLS CUI 2011AA
C0549206
Hypersensitivity to the active substance or to any of the excipients.
Beschreibung

Hypersensitivity to the active substance or to any of the excipients.

Datentyp

boolean

Alias
UMLS CUI 2011AA
C0020517
SNOMED CT 2011_0131
257550005
ICD-10-CM Version 2010
T78.40
UMLS CUI 2011AA
C0205177
SNOMED CT 2011_0131
55561003
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C0015237
SNOMED CT 2011_0131
360215002
Patients with moderate or severe (Child-Pugh B or C) hepatic impairment.
Beschreibung

Patients with moderate or severe (Child-Pugh B or C) hepatic impairment.

Datentyp

boolean

Alias
UMLS CUI 2011AA
C1881878
UMLS CUI 2011AA
C0205082
SNOMED CT 2011_0131
24484000
UMLS CUI 2011AA
C2347612
UMLS CUI 2011AA
C0948807
MedDRA 14.1
10052254
Rifampicin should not be used with Aptivus (tipranavir) because co-administration may cause large decreases in tipranavir concentrations which may in turn significantly decrease the tipranavir therapeutic effect.
Beschreibung

Rifampicin should not be used with Aptivus (tipranavir) because co-administration may cause large decreases in tipranavir concentrations which may in turn significantly decrease the tipranavir therapeutic effect.

Datentyp

boolean

Alias
UMLS CUI 2011AA
C0035608
SNOMED CT 2011_0131
387159009
LOINC Version 232
MTHU008474
UMLS CUI 2011AA
C1518422
UMLS CUI 2011AA
C0556895
SNOMED CT 2011_0131
229554006
UMLS CUI 2011AA
C1612190
UMLS CUI 2011AA
CL420107
UMLS CUI 2011AA
C0547047
SNOMED CT 2011_0131
260370003
UMLS CUI 2011AA
C1612190
UMLS CUI 2011AA
C1527144
Herbal preparations containing St John's wort must not be used while taking Aptivus (tipranavir) due to the risk of decreased plasma concentrations and reduced clinical effects of tipranavir.
Beschreibung

Herbal preparations containing St John's wort must not be used while taking Aptivus (tipranavir) due to the risk of decreased plasma concentrations and reduced clinical effects of tipranavir.

Datentyp

boolean

Alias
UMLS CUI 2011AA
C1518422
UMLS CUI 2011AA
C1524063
SNOMED CT 2011_0131
260676000
UMLS CUI 2011AA
C1360419
UMLS CUI 2011AA
C0332256
SNOMED CT 2011_0131
42504009
UMLS CUI 2011AA
C0936242
SNOMED CT 2011_0131
51621002
UMLS CUI 2011AA
C0347984
SNOMED CT 2011_0131
371881003
UMLS CUI 2011AA
C1512806
UMLS CUI 2011AA
C1612190
UMLS CUI 2011AA
CL420107
UMLS CUI 2011AA
C0035647
SNOMED CT 2011_0131
30207005
HL7 V3 2006_05
RSK
UMLS CUI 2011AA
C0205216
SNOMED CT 2011_0131
1250004
HL7 V3 2006_05
D
UMLS CUI 2011AA
C0683150
UMLS CUI 2011AA
C0392756
SNOMED CT 2011_0131
260400001
UMLS CUI 2011AA
C0205210
SNOMED CT 2011_0131
58147004
UMLS CUI 2011AA
C1280500
SNOMED CT 2011_0131
253861007
UMLS CUI 2011AA
C1612190
Co-administration of Aptivus (tipranavir) with low dose Norvir (ritonavir), with active substances that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events is contraindicated. These active substances include antiarrhythmics (amiodarone, bepridil, quinidine), antihistamines (astemizole, terfenadine), ergot derivatives (dihydroergotamine, ergonovine, ergotamine, methylergonovine), gastrointestinal motility agents (cisapride), neuroleptics (pimozide, sertindole), sedatives/hypnotics (triazolam) and HMG-CoA reductase inhibitors (simvastatin and lovastatin). In addition, co-administration of Aptivus (tipranavir) with low dose Norvir (ritonavir), with drugs that are highly dependent on CYP2D6 for clearance, such as the antiarrhythmics flecainide and propafenone, is contraindicated.
Beschreibung

Co-administration of Aptivus (tipranavir) with low dose Norvir (ritonavir), with active substances that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events is contraindicated. These active substances include antiarrhythmics (amiodarone, bepridil, quinidine), antihistamines (astemizole, terfenadine), ergot derivatives (dihydroergotamine, ergonovine, ergotamine, methylergonovine), gastrointestinal motility agents (cisapride), neuroleptics (pimozide, sertindole), sedatives/hypnotics (triazolam) and HMG-CoA reductase inhibitors (simvastatin and lovastatin). In addition, co-administration of Aptivus (tipranavir) with low dose Norvir (ritonavir), with drugs that are highly dependent on CYP2D6 for clearance, such as the antiarrhythmics flecainide and propafenone, is contraindicated.

Datentyp

boolean

Alias
UMLS CUI 2011AA
C1444657
SNOMED CT 2011_0131
410536001
UMLS CUI 2011AA
CL415222
UMLS CUI 2011AA
C1533734
SNOMED CT 2011_0131
416118004
UMLS CUI 2011AA
C1612190
UMLS CUI 2011AA
C1708745
UMLS CUI 2011AA
C0292818
SNOMED CT 2011_0131
386896009
LOINC Version 232
MTHU013855
UMLS CUI 2011AA
C0205177
SNOMED CT 2011_0131
55561003
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C0205250
SNOMED CT 2011_0131
75540009
UMLS CUI 2011AA
C0851827
SNOMED CT 2011_0131
371154000
UMLS CUI 2011AA
C1413881
UMLS CUI 2011AA
C2825073
UMLS CUI 2011AA
CL414623
UMLS CUI 2011AA
C0683150
UMLS CUI 2011AA
C0332281
SNOMED CT 2011_0131
47429007
UMLS CUI 2011AA
C2826307
UMLS CUI 2011AA
C1610642
SNOMED CT 2011_0131
440181000
UMLS CUI 2011AA
C0332152
SNOMED CT 2011_0131
288556008
UMLS CUI 2011AA
C0205177
SNOMED CT 2011_0131
55561003
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C0332257
SNOMED CT 2011_0131
55919000
UMLS CUI 2011AA
C0003195
SNOMED CT 2011_0131
67507000
UMLS CUI 2011AA
C0002598
SNOMED CT 2011_0131
372821002
LOINC Version 232
MTHU004841
UMLS CUI 2011AA
C0005116
SNOMED CT 2011_0131
372503006
UMLS CUI 2011AA
C0034414
SNOMED CT 2011_0131
372697008
LOINC Version 232
MTHU005039
UMLS CUI 2011AA
C0003360
SNOMED CT 2011_0131
372806008
LOINC Version 232
MTHU003328
UMLS CUI 2011AA
C0699606
SNOMED CT 2011_0131
387333002
LOINC Version 232
MTHU002553
UMLS CUI 2011AA
C0085173
SNOMED CT 2011_0131
387089004
LOINC Version 232
MTHU003387
UMLS CUI 2011AA
C0870507
UMLS CUI 2011AA
C0012291
SNOMED CT 2011_0131
387267005
UMLS CUI 2011AA
C0014704
SNOMED CT 2011_0131
126071000
UMLS CUI 2011AA
C0014710
SNOMED CT 2011_0131
395975005
LOINC Version 232
MTHU024862
UMLS CUI 2011AA
C0025760
SNOMED CT 2011_0131
126074008
LOINC Version 232
MTHU007397
UMLS CUI 2011AA
C0017184
UMLS CUI 2011AA
C1254351
UMLS CUI 2011AA
C0072916
SNOMED CT 2011_0131
387164008
LOINC Version 232
MTHU012783
UMLS CUI 2011AA
C0040615
SNOMED CT 2011_0131
10784006, 372482001
LOINC Version 232
MTHU003337
UMLS CUI 2011AA
C0031935
SNOMED CT 2011_0131
386848009
LOINC Version 232
MTHU003380
UMLS CUI 2011AA
C0084528
SNOMED CT 2011_0131
418732002
UMLS CUI 2011AA
C0036557
SNOMED CT 2011_0131
372614000
UMLS CUI 2011AA
C0020591
SNOMED CT 2011_0131
372585002
LOINC Version 232
MTHU015316
UMLS CUI 2011AA
C0040879
SNOMED CT 2011_0131
386984001
LOINC Version 232
MTHU003366
UMLS CUI 2011AA
C0360714
SNOMED CT 2011_0131
372912004
UMLS CUI 2011AA
C0074554
SNOMED CT 2011_0131
387584000
UMLS CUI 2011AA
C0024027
SNOMED CT 2011_0131
96303004
UMLS CUI 2011AA
C1444657
SNOMED CT 2011_0131
410536001
UMLS CUI 2011AA
CL415222
UMLS CUI 2011AA
C1533734
SNOMED CT 2011_0131
416118004
UMLS CUI 2011AA
C1612190
UMLS CUI 2011AA
C1708745
UMLS CUI 2011AA
C0292818
SNOMED CT 2011_0131
386896009
LOINC Version 232
MTHU013855
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C0205250
SNOMED CT 2011_0131
75540009
UMLS CUI 2011AA
C0851827
SNOMED CT 2011_0131
371154000
UMLS CUI 2011AA
C1332830
UMLS CUI 2011AA
C2825073
UMLS CUI 2011AA
C0003195
SNOMED CT 2011_0131
67507000
UMLS CUI 2011AA
C0016229
SNOMED CT 2011_0131
372751001
LOINC Version 232
MTHU004259
UMLS CUI 2011AA
C0033429
SNOMED CT 2011_0131
372910007
LOINC Version 232
MTHU012323
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Einschlusskriterien
CL425202 (UMLS CUI 2011AA)
age at least 18 Years
Item
Alter mindestens 18 Jahre
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Highly pre-treated male and female adult patients with virus resistant to multiple protease inhibitors. Aptivus (tipranavir), co-administered with low dose Norvir (ritonavir), is indicated for combination antiretroviral treatment of HIV-1 infection in highly pre-treated adult patients with virus resistant to multiple protease inhibitors.
Item
Highly pre-treated male and female adult patients with virus resistant to multiple protease inhibitors. Aptivus (tipranavir), co-administered with low dose Norvir (ritonavir), is indicated for combination antiretroviral treatment of HIV-1 infection in highly pre-treated adult patients with virus resistant to multiple protease inhibitors.
boolean
C0205250 (UMLS CUI 2011AA)
75540009 (SNOMED CT 2011_0131)
C1514463 (UMLS CUI 2011AA)
C0024554 (UMLS CUI 2011AA)
248153007 (SNOMED CT 2011_0131)
M (HL7 V3 2006_05)
C0015780 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C0700597 (UMLS CUI 2011AA)
41847000 (SNOMED CT 2011_0131)
C1444092 (UMLS CUI 2011AA)
409795000 (SNOMED CT 2011_0131)
C0439064 (UMLS CUI 2011AA)
255204007 (SNOMED CT 2011_0131)
C0033607 (UMLS CUI 2011AA)
412127001 (SNOMED CT 2011_0131)
C1612190 (UMLS CUI 2011AA)
CL415222 (UMLS CUI 2011AA)
C1521801 (UMLS CUI 2011AA)
C1708745 (UMLS CUI 2011AA)
C0292818 (UMLS CUI 2011AA)
386896009 (SNOMED CT 2011_0131)
MTHU013855 (LOINC Version 232)
C1444656 (UMLS CUI 2011AA)
410535002 (SNOMED CT 2011_0131)
C0556895 (UMLS CUI 2011AA)
229554006 (SNOMED CT 2011_0131)
C1963724 (UMLS CUI 2011AA)
10067326 (MedDRA 14.1)
MTHU000163 (LOINC Version 232)
C2363741 (UMLS CUI 2011AA)
10068341 (MedDRA 14.1)
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
Item Group
Ausschlusskriterien
CL425201 (UMLS CUI 2011AA)
Age < 18 years
Item
Alter < 18 Jahre
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
pregnant female patients
Item
pregnant female patients
boolean
C0549206 (UMLS CUI 2011AA)
Hypersensitivity to the active substance or to any of the excipients.
Item
Hypersensitivity to the active substance or to any of the excipients.
boolean
C0020517 (UMLS CUI 2011AA)
257550005 (SNOMED CT 2011_0131)
T78.40 (ICD-10-CM Version 2010)
C0205177 (UMLS CUI 2011AA)
55561003 (SNOMED CT 2011_0131)
C0013227 (UMLS CUI 2011AA)
C0015237 (UMLS CUI 2011AA)
360215002 (SNOMED CT 2011_0131)
Patients with moderate or severe (Child-Pugh B or C) hepatic impairment.
Item
Patients with moderate or severe (Child-Pugh B or C) hepatic impairment.
boolean
C1881878 (UMLS CUI 2011AA)
C0205082 (UMLS CUI 2011AA)
24484000 (SNOMED CT 2011_0131)
C2347612 (UMLS CUI 2011AA)
C0948807 (UMLS CUI 2011AA)
10052254 (MedDRA 14.1)
Rifampicin should not be used with Aptivus (tipranavir) because co-administration may cause large decreases in tipranavir concentrations which may in turn significantly decrease the tipranavir therapeutic effect.
Item
Rifampicin should not be used with Aptivus (tipranavir) because co-administration may cause large decreases in tipranavir concentrations which may in turn significantly decrease the tipranavir therapeutic effect.
boolean
C0035608 (UMLS CUI 2011AA)
387159009 (SNOMED CT 2011_0131)
MTHU008474 (LOINC Version 232)
C1518422 (UMLS CUI 2011AA)
C0556895 (UMLS CUI 2011AA)
229554006 (SNOMED CT 2011_0131)
C1612190 (UMLS CUI 2011AA)
CL420107 (UMLS CUI 2011AA)
C0547047 (UMLS CUI 2011AA)
260370003 (SNOMED CT 2011_0131)
C1612190 (UMLS CUI 2011AA)
C1527144 (UMLS CUI 2011AA)
Herbal preparations containing St John's wort must not be used while taking Aptivus (tipranavir) due to the risk of decreased plasma concentrations and reduced clinical effects of tipranavir.
Item
Herbal preparations containing St John's wort must not be used while taking Aptivus (tipranavir) due to the risk of decreased plasma concentrations and reduced clinical effects of tipranavir.
boolean
C1518422 (UMLS CUI 2011AA)
C1524063 (UMLS CUI 2011AA)
260676000 (SNOMED CT 2011_0131)
C1360419 (UMLS CUI 2011AA)
C0332256 (UMLS CUI 2011AA)
42504009 (SNOMED CT 2011_0131)
C0936242 (UMLS CUI 2011AA)
51621002 (SNOMED CT 2011_0131)
C0347984 (UMLS CUI 2011AA)
371881003 (SNOMED CT 2011_0131)
C1512806 (UMLS CUI 2011AA)
C1612190 (UMLS CUI 2011AA)
CL420107 (UMLS CUI 2011AA)
C0035647 (UMLS CUI 2011AA)
30207005 (SNOMED CT 2011_0131)
RSK (HL7 V3 2006_05)
C0205216 (UMLS CUI 2011AA)
1250004 (SNOMED CT 2011_0131)
D (HL7 V3 2006_05)
C0683150 (UMLS CUI 2011AA)
C0392756 (UMLS CUI 2011AA)
260400001 (SNOMED CT 2011_0131)
C0205210 (UMLS CUI 2011AA)
58147004 (SNOMED CT 2011_0131)
C1280500 (UMLS CUI 2011AA)
253861007 (SNOMED CT 2011_0131)
C1612190 (UMLS CUI 2011AA)
Co-administration of Aptivus (tipranavir) with low dose Norvir (ritonavir), with active substances that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events is contraindicated. These active substances include antiarrhythmics (amiodarone, bepridil, quinidine), antihistamines (astemizole, terfenadine), ergot derivatives (dihydroergotamine, ergonovine, ergotamine, methylergonovine), gastrointestinal motility agents (cisapride), neuroleptics (pimozide, sertindole), sedatives/hypnotics (triazolam) and HMG-CoA reductase inhibitors (simvastatin and lovastatin). In addition, co-administration of Aptivus (tipranavir) with low dose Norvir (ritonavir), with drugs that are highly dependent on CYP2D6 for clearance, such as the antiarrhythmics flecainide and propafenone, is contraindicated.
Item
Co-administration of Aptivus (tipranavir) with low dose Norvir (ritonavir), with active substances that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events is contraindicated. These active substances include antiarrhythmics (amiodarone, bepridil, quinidine), antihistamines (astemizole, terfenadine), ergot derivatives (dihydroergotamine, ergonovine, ergotamine, methylergonovine), gastrointestinal motility agents (cisapride), neuroleptics (pimozide, sertindole), sedatives/hypnotics (triazolam) and HMG-CoA reductase inhibitors (simvastatin and lovastatin). In addition, co-administration of Aptivus (tipranavir) with low dose Norvir (ritonavir), with drugs that are highly dependent on CYP2D6 for clearance, such as the antiarrhythmics flecainide and propafenone, is contraindicated.
boolean
C1444657 (UMLS CUI 2011AA)
410536001 (SNOMED CT 2011_0131)
CL415222 (UMLS CUI 2011AA)
C1533734 (UMLS CUI 2011AA)
416118004 (SNOMED CT 2011_0131)
C1612190 (UMLS CUI 2011AA)
C1708745 (UMLS CUI 2011AA)
C0292818 (UMLS CUI 2011AA)
386896009 (SNOMED CT 2011_0131)
MTHU013855 (LOINC Version 232)
C0205177 (UMLS CUI 2011AA)
55561003 (SNOMED CT 2011_0131)
C0013227 (UMLS CUI 2011AA)
C0205250 (UMLS CUI 2011AA)
75540009 (SNOMED CT 2011_0131)
C0851827 (UMLS CUI 2011AA)
371154000 (SNOMED CT 2011_0131)
C1413881 (UMLS CUI 2011AA)
C2825073 (UMLS CUI 2011AA)
CL414623 (UMLS CUI 2011AA)
C0683150 (UMLS CUI 2011AA)
C0332281 (UMLS CUI 2011AA)
47429007 (SNOMED CT 2011_0131)
C2826307 (UMLS CUI 2011AA)
C1610642 (UMLS CUI 2011AA)
440181000 (SNOMED CT 2011_0131)
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C0205177 (UMLS CUI 2011AA)
55561003 (SNOMED CT 2011_0131)
C0013227 (UMLS CUI 2011AA)
C0332257 (UMLS CUI 2011AA)
55919000 (SNOMED CT 2011_0131)
C0003195 (UMLS CUI 2011AA)
67507000 (SNOMED CT 2011_0131)
C0002598 (UMLS CUI 2011AA)
372821002 (SNOMED CT 2011_0131)
MTHU004841 (LOINC Version 232)
C0005116 (UMLS CUI 2011AA)
372503006 (SNOMED CT 2011_0131)
C0034414 (UMLS CUI 2011AA)
372697008 (SNOMED CT 2011_0131)
MTHU005039 (LOINC Version 232)
C0003360 (UMLS CUI 2011AA)
372806008 (SNOMED CT 2011_0131)
MTHU003328 (LOINC Version 232)
C0699606 (UMLS CUI 2011AA)
387333002 (SNOMED CT 2011_0131)
MTHU002553 (LOINC Version 232)
C0085173 (UMLS CUI 2011AA)
387089004 (SNOMED CT 2011_0131)
MTHU003387 (LOINC Version 232)
C0870507 (UMLS CUI 2011AA)
C0012291 (UMLS CUI 2011AA)
387267005 (SNOMED CT 2011_0131)
C0014704 (UMLS CUI 2011AA)
126071000 (SNOMED CT 2011_0131)
C0014710 (UMLS CUI 2011AA)
395975005 (SNOMED CT 2011_0131)
MTHU024862 (LOINC Version 232)
C0025760 (UMLS CUI 2011AA)
126074008 (SNOMED CT 2011_0131)
MTHU007397 (LOINC Version 232)
C0017184 (UMLS CUI 2011AA)
C1254351 (UMLS CUI 2011AA)
C0072916 (UMLS CUI 2011AA)
387164008 (SNOMED CT 2011_0131)
MTHU012783 (LOINC Version 232)
C0040615 (UMLS CUI 2011AA)
10784006, 372482001 (SNOMED CT 2011_0131)
MTHU003337 (LOINC Version 232)
C0031935 (UMLS CUI 2011AA)
386848009 (SNOMED CT 2011_0131)
MTHU003380 (LOINC Version 232)
C0084528 (UMLS CUI 2011AA)
418732002 (SNOMED CT 2011_0131)
C0036557 (UMLS CUI 2011AA)
372614000 (SNOMED CT 2011_0131)
C0020591 (UMLS CUI 2011AA)
372585002 (SNOMED CT 2011_0131)
MTHU015316 (LOINC Version 232)
C0040879 (UMLS CUI 2011AA)
386984001 (SNOMED CT 2011_0131)
MTHU003366 (LOINC Version 232)
C0360714 (UMLS CUI 2011AA)
372912004 (SNOMED CT 2011_0131)
C0074554 (UMLS CUI 2011AA)
387584000 (SNOMED CT 2011_0131)
C0024027 (UMLS CUI 2011AA)
96303004 (SNOMED CT 2011_0131)
C1444657 (UMLS CUI 2011AA)
410536001 (SNOMED CT 2011_0131)
CL415222 (UMLS CUI 2011AA)
C1533734 (UMLS CUI 2011AA)
416118004 (SNOMED CT 2011_0131)
C1612190 (UMLS CUI 2011AA)
C1708745 (UMLS CUI 2011AA)
C0292818 (UMLS CUI 2011AA)
386896009 (SNOMED CT 2011_0131)
MTHU013855 (LOINC Version 232)
C0013227 (UMLS CUI 2011AA)
C0205250 (UMLS CUI 2011AA)
75540009 (SNOMED CT 2011_0131)
C0851827 (UMLS CUI 2011AA)
371154000 (SNOMED CT 2011_0131)
C1332830 (UMLS CUI 2011AA)
C2825073 (UMLS CUI 2011AA)
C0003195 (UMLS CUI 2011AA)
67507000 (SNOMED CT 2011_0131)
C0016229 (UMLS CUI 2011AA)
372751001 (SNOMED CT 2011_0131)
MTHU004259 (LOINC Version 232)
C0033429 (UMLS CUI 2011AA)
372910007 (SNOMED CT 2011_0131)
MTHU012323 (LOINC Version 232)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video